wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36064908-5AFD675A-5554-4644-B5D3-B833F06EEE9F
Q36064908-5AFD675A-5554-4644-B5D3-B833F06EEE9F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36064908-5AFD675A-5554-4644-B5D3-B833F06EEE9F
Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast Cancer
P2860
Q36064908-5AFD675A-5554-4644-B5D3-B833F06EEE9F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36064908-5AFD675A-5554-4644-B5D3-B833F06EEE9F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9c0464d9cf7a16836eea1980a8d4bd5d62a6be14
P2860
High HER2 expression correlates with response to the combination of lapatinib and trastuzumab.